about
Kinetic analysis of human protein arginine N-methyltransferase 2: formation of monomethyl- and asymmetric dimethyl-arginine residues on histone H4Calcium-induced folding of a fragment of calmodulin composed of EF-hands 2 and 3PRMT2 interacts with splicing factors and regulates the alternative splicing of BCL-X.Simultaneous quantification of reparixin and paclitaxel in plasma and urine using ultra performance liquid chromatography-tandem mass spectroscopy (UHPLC-MS/MS): Application to a preclinical pharmacokinetic study in rats.Approaches to measuring the activities of protein arginine N-methyltransferasesExperimental Autoimmune Encephalomyelitis (EAE)-Induced Elevated Expression of the E1 Isoform of Methyl CpG Binding Protein 2 (MeCP2E1): Implications in Multiple Sclerosis (MS)-Induced Neurological Disability and Associated Myelin DamageTranscriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS).Pharmacokinetic Analysis of an Oral Multicomponent Joint Dietary Supplement (Phycox®) in Dogs.Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.Förster resonance energy transfer measurements of cofactor-dependent effects on protein arginine N-methyltransferase homodimerization.Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.Sources of S-adenosyl-L-homocysteine background in measuring protein arginine N-methyltransferase activity using tandem mass spectrometry.MS³ fragmentation patterns of monomethylarginine species and the quantification of all methylarginine species in yeast using MRM³.A kinetic study of human protein arginine N-methyltransferase 6 reveals a distributive mechanism.Evaluation of cefazolin antimicrobial prophylaxis during cardiac surgery with cardiopulmonary bypass.Quantification of cefazolin in serum and adipose tissue by ultra high performance liquid chromatography-Tandem mass spectrometry (UHPLC-MS/MS): application to a pilot study of obese women undergoing cesarean delivery.Increased Post-Translational Lysine Acetylation of Myelin Basic Protein Is Associated with Peak Neurological Disability in a Mouse Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.Physiologic Changes in the Heart Following Cessation of Mechanical Ventilation in a Porcine Model of Donation After Circulatory Death: Implications for Cardiac Transplantation.Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids.Enantiospecific analysis of 8-prenylnaringenin in biological fluids by liquid-chromatography-electrospray ionization mass spectrometry: application to preclinical pharmacokinetic investigations.Absolute Oral Bioavailability of Creatine Monohydrate in Rats: Debunking a Myth.Antimicrobial Prophylaxis for Patients Undergoing Cardiac Surgery: Intraoperative Cefazolin Concentrations and Sternal Wound InfectionsPeptide binding by a fragment of calmodulin composed of EF-hands 2 and 3Peptidic partial bisubstrates as inhibitors of the protein arginine N-methyltransferasesArginine methylation in yeast proteins during stationary-phase growth and heat shockHDAC inhibitors induce global changes in histone lysine and arginine methylation and alter expression of lysine demethylasesProtein arginine N-methyltransferase substrate preferences for different nη-substituted arginyl peptidesSelective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying Enzymes
P50
Q24320243-E1866353-1AC0-4EAB-9C86-954CB5FAA63DQ27644660-33F81706-FE73-4033-A004-6F0C981162F3Q30008797-AF85974D-3FEE-4956-B001-8D5862BA6016Q33469791-D069377C-AE16-4A77-AC66-914B60ED1777Q33598698-67C97FC7-4091-4EFC-8E9F-6FF5EE3E01E0Q33838894-EB7B8FB0-9AF4-4978-8344-44B88A99E80BQ38314584-2FAE46CF-E70B-41CE-B3F2-B11E51D48EDDQ38618573-136BACC1-73CB-44D1-8324-F02C589AC76CQ38833038-42D8824D-946E-4972-83AA-FD8B8669607BQ41294816-37709697-628F-464C-ABA6-D99103E8104CQ42940713-F396A53D-C78C-4D3C-8D33-BADCF4ADDD63Q43280515-F09D3CD9-6AA0-4775-9FA4-8E81178AB409Q44049285-86CB1522-D496-4DE3-8322-97B2F1FC77EAQ46762026-F7E568E8-9DAD-46CD-81A1-698965486679Q47297439-9926BB7C-5449-4531-B484-6EAB6A372BA2Q47404179-B857A011-7801-45B3-AAAE-381D983E6CC5Q47431443-F544A006-630D-458C-851A-05E7EE8EA80CQ47616504-C759DF90-DBB2-40D5-9A01-9767294D5A4AQ48204217-DD6CBE90-3C11-4ECB-BE49-10359BE43186Q51134203-2977A50F-9380-4077-A5C3-4C06780149AEQ55069818-050D37FE-B6E4-4304-8F47-56AAD3A3B057Q57789726-6DEF4DAD-C43D-43DB-8F15-1282AC3203A8Q80535091-5D4CA882-5434-4879-AB23-39993A160099Q84075165-773A0D58-B3B5-4886-8878-B9866F7AAC19Q85623126-8F5B5DD0-A854-448B-B68E-0A1DB836DFD5Q87000069-3F73FF3D-F9B3-4557-ACAB-C0F5205E8FDDQ87418508-3D9D6804-70ED-4A56-A8E6-ACD89DE4635BQ89417771-25E5F78F-E0FA-4EF1-A1F2-8FBB95B72749
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ted M. Lakowski
@ast
Ted M. Lakowski
@en
Ted M. Lakowski
@es
Ted M. Lakowski
@nl
Ted M. Lakowski
@sl
type
label
Ted M. Lakowski
@ast
Ted M. Lakowski
@en
Ted M. Lakowski
@es
Ted M. Lakowski
@nl
Ted M. Lakowski
@sl
prefLabel
Ted M. Lakowski
@ast
Ted M. Lakowski
@en
Ted M. Lakowski
@es
Ted M. Lakowski
@nl
Ted M. Lakowski
@sl
P106
P1153
16417433200
P2038
Ted_Lakowski
P21
P31
P496
0000-0002-6625-6717